Search Results

GW3965 HCl 50mg  | Purity Not Available

Selleck Chemicals

GW3965 HCl is a potent, selective LXR agonist for hLXRα and hLXRβ with EC50 of 190 and 30 nM in cell-free assays, respectively.

More Information Supplier Page

GW3965 HCl 10mM/1mL  | Purity Not Available

Selleck Chemicals

GW3965 HCl is a potent, selective LXR agonist for hLXRα and hLXRβ with EC50 of 190 and 30 nM in cell-free assays, respectively.

More Information Supplier Page

URB597 25mg  | Purity Not Available

Selleck Chemicals

URB597 (KDS-4103) is a potent, orally bioavailable FAAH inhibitor with IC50 of 4.6 nM, with no activity on other cannabinoid-related targets. Phase 1.

More Information Supplier Page

BMS-378806 5mg  | Purity Not Available

Selleck Chemicals

BMS-378806 (BMS 806) selectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in virus.

More Information Supplier Page

BMS-378806 50mg  | Purity Not Available

Selleck Chemicals

BMS-378806 (BMS 806) selectively inhibits the binding of HIV-1 gp120 to the CD4 receptor with EC50 of 0.85-26.5 nM in virus.

More Information Supplier Page

NPS-2143 10mg  | Purity Not Available

Selleck Chemicals

NPS-2143 (SB262470) is a novel potent and selective antagonist of Ca(2+) receptor with IC50 of 43 nM.

More Information Supplier Page

NPS-2143 50mg  | Purity Not Available

Selleck Chemicals

NPS-2143 (SB262470) is a novel potent and selective antagonist of Ca(2+) receptor with IC50 of 43 nM.

More Information Supplier Page

Rebastinib (DCC-2036) 10mg  | Purity Not Available

Selleck Chemicals

Rebastinib (DCC-2036) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.

More Information Supplier Page

OSI-027 50mg  | Purity Not Available

Selleck Chemicals

OSI-027 (ASP4786, CERC 006, AEVI-006) is a selective and potent dual inhibitor of mTORC1 and mTORC2 with IC50 of 22 nM and 65 nM in cell-free assays, and more than 100-fold selectivity observed for mTOR than PI3Kα, PI3Kβ, PI3Kγ or DNA-PK. OSI-027 induces autophagy in cancer cells.

More Information Supplier Page

OSI-027 10mM/1mL  | Purity Not Available

Selleck Chemicals

OSI-027 (ASP4786, CERC 006, AEVI-006) is a selective and potent dual inhibitor of mTORC1 and mTORC2 with IC50 of 22 nM and 65 nM in cell-free assays, and more than 100-fold selectivity observed for mTOR than PI3Kα, PI3Kβ, PI3Kγ or DNA-PK. OSI-027 induces autophagy in cancer cells.

More Information Supplier Page